Pacific Biosciences

$23.32 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Pacific Biosciences

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.

Stock Analysis

last close $23.39
1-mo return -8.2%
3-mo return -21%
avg daily vol. 2.29M
52-week high 53.69
52-week low 14.45
market cap. $5.8B
forward pe -
annual div. -
roe -7.6%
ltg forecast -
dividend yield -
annual rev. $122M
inst own. 84%
baraka

Subscribe now for daily local and international financial news

Subscribe